Characteristics, mortality, associated variables with death, and therapeutic response among HIV-positive, solid organ transplant (SOT), and non-HIV-positive/non-transplant (NHNT) patients with cryptococcosis: First multicenter cohort study in Brazil

Francelise Bridi Cavassin(Faculdade de Administração Ciências Educação e Letras), Flávio Queiroz‐Telles(Hospital de Clínicas Universidade Federal do Paraná), Diego R. Falci(Hospital de Clínicas de Porto Alegre), Carla Sakuma de Oliveira(Hospital Universitário Regional do Norte do Paraná), Giovanni Luís Breda(Radboud University Nijmegen), João Luiz Baú-Carneiro, Marcello Mihailenko Chaves Magri(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), José Ernesto Vidal(Instituto de Infectologia Emílio Ribas), Talita Teles Teixeira Pereira(Hospital São Rafael), Maíra Araujo Félix(Instituto de Infectologia Emílio Ribas), Mirela Pereira Lima Abrão(Universidade Federal de Goiás), Renata de Bastos Ascenço Soares(Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais), Julia Raquel da Silva do Ó(Pontifícia Universidade Católica de Goiás), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Caroline Martins Rego(Instituto de Infectologia Emílio Ribas), Paula Pacheco Katopodis(Pontifícia Universidade Católica de Goiás), Cássia Silva de Miranda Godoy(Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais), Mariane Taborda(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo)
Medical Mycology
January 27, 2023
10.1093/mmy/myad011
Cited by 6

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
|The Lancet|2022|467
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
|The Lancet Infectious Diseases|2021|450
Chromoblastomycosis
|Clinical Microbiology Reviews|2016|339